Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Is The Catheter-Related Bloodstream Infection Market Expected To Grow In Terms Of Size?

The market size for catheter-related bloodstream infections has seen a significant increase in the past few years. Its expansion is expected to continue from $1.53 billion in 2024, to $1.62 billion in 2025, representing a compound annual growth rate (CAGR) of 5.9%. Factors contributing to this development during the historical period include the escalating cases of chronic diseases, elevated levels of awareness and professional education, an increase in hospital-related infections, a burgeoning elderly population, as well as improved infection management programs in healthcare environments and hospitals.

Expectations are high for the catheter-related bloodstream infection market, which is set to experience considerable growth in the coming years. It is forecast to reach a value of $2.01 billion by 2029, increasing at a compound annual growth rate (CAGR) of 5.6%. The probable expansion during this period is largely due to factors such as the rise in healthcare-associated infections (hais), growing awareness and training, improved programs for infection control practices, development of healthcare infrastructure, growth in the elderly population, and supportive governmental policies and initiatives. The market in this forecast period illustrates the key trends of advancements in biomaterials, intelligent catheter technology, new and more effective catheter lock solutions with heightened antimicrobial properties, advances in sterilization techniques for catheters, and the introduction of automated flushing systems.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16646&type=smp

What Are The Primary Factors Supporting The Catheter-Related Bloodstream Infection Market Expansion?

The increasing occurrence of infections contracted in hospitals is predicted to expedite the expansion of the market for catheter-related bloodstream infections. These hospital-acquired infections (HAIs) are those that are contracted by patients during their treatment for other illnesses in a healthcare facility, usually developing 48 hours or later after admission. The surge in hospital-acquired infections can be connected to several factors such as resistance to antimicrobial agents, insufficient infection control measures, and patient vulnerability. Due to their invasive character and capacity for microbial colonization, catheter-related bloodstream infections substantially contribute to hospital-acquired infections, posing threats to patients with internal catheters. For example, the National Library of Medicine, a US-based biomedical library, reported in January 2023 that the worldwide healthcare-associated infection (HAI) rate was 0.14%, witnessing an annual increase of 0.06%. Consequently, the escalating incidence of hospital-acquired infections will steer the progress of the catheter-related bloodstream infection market.

Which Segmentation Categories Are Highlighted In The Catheter-Related Bloodstream Infection Market Analysis?

The catheter-related bloodstream infectionmarket covered in this report is segmented –

1) By Treatment: Antibiotic Lock Therapy; Anti-Microbial Agents

2) By Source Of Infection Or Causative Agents: Staphylococcus Aureus; Acinetobacter Baumannii; Escherichia Coli (E. Coli); Klebsiella Pneumoniae (K. Pneumonia); Candida Species (Candida Sp.); Pseudomonas Aeruginosa (P. Aeruginosa); Other Source Of Infection Or Causative Agents

3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

Subsegments:

1) By Antibiotic Lock Therapy: Catheter Lock Solutions (Antibiotic-based); Combination Antibiotic Lock Therapy

2) By Anti-Microbial Agents: Antibiotics; Antifungal Agents; Antiseptic Agents

Which Notable Trends Are Transforming The Catheter-Related Bloodstream Infection Market Outlook?

Leading businesses in the catheter-related bloodstream infection sector are advancing innovative catheter lock techniques that aim to improve infection prevention and enhance patient results. A catheter lock solution is a fluid that is instilled into a catheter between uses to avoid infections and keep the catheter patent. For example, in November 2023, CorMedix Inc., a US biopharmaceutical firm that specialises in the development and commercialisation of therapeutic products, secured approval from the US Food and Drug Administration for its DefenCath (taurolidine and heparin) catheter lock solution for adult kidney failure patients needing chronic hemodialysis via a central venous catheter (CVC). This antifungal and antimicrobial solution, combining anticoagulation properties of heparin with taurolidine’s extensive antimicrobial characteristics, is designed specifically to diminish catheter-related bloodstream infections (CRBSIs).

Which Organizations Are At The Forefront Of The Catheter-Related Bloodstream Infection Market?

Major companies operating in the catheter-related bloodstream infection market are Pfizer Inc., Johnson & Johnson Services Inc., Novartis AG, 3M Company, Eli Lilly and Company, Fresenius Medical Care AG & Co. KGaA, Becton Dickinson and Company, Viatris Inc., B. Braun Medical Inc., Aurobindo Pharma Limited, Lupin Ltd., Xellia Pharmaceuticals Ltd., SteriMax Inc., Geistlich Pharma AG, Bactiguard AB, Hetero Healthcare Ltd., TauroPharm GmbH, Advacare Pharma, Citus Pharmaceuticals Inc., CorMedix Inc., JoinHub Pharma LLP, IntegraDose Compounding Services LLC

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/catheter-related-bloodstream-infection-global-market-report

Which Geographic Regions Are Creating Strong Demand In The Catheter-Related Bloodstream Infection Market?

North America was the largest region in the catheter-related bloodstream infection market in 2024. The regions covered in the catheter-related bloodstream infection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=16646&type=smp

Browse Through More Reports Similar to the Global Catheter-Related Bloodstream Infection Market 2025, By The Business Research Company

Catheters Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/catheters-global-market-report

Peripheral Iv Catheters Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/peripheral-iv-catheters-global-market-report

Intravascular Catheters Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/intravascular-catheters-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model